Phenotype at diagnosis predicts recurrence rates in Crohn's disease

Gut

Volumn 55, Issue 8, 2006, Pages 1124-1130

  Wolters, F L ^a   Russel, M G ^b   Sijbrandij, J ^c   Ambergen, T ^c   Odes, S ^d   Riis, L ^e   Langholz, E ^e   Politi, P ^f   Qasim, A ^g   Koutroubakis, I ^h   Tsianos, E ⁱ   Vermeire, S ^j   Freitas, J ^k   Van Zeijl, G ^c   Hoie, O ^l   Bernklev, T ^l   Beltrami, M ^m   Rodriguez, D ⁿ   Stockbrugger R W ^a   Mourn, B ^l  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f CREMONA HOSPITAL   (Italy)

^g ADELAIDE AND MEATH HOSPITAL   (Ireland)

^h UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

ⁱ UNIVERSITY OF IOANNINA   (Greece)

^j UNIVERSITY OF LEUVEN   (Belgium)

^k Department of Gastroenterology   (Portugal)

^l Oestfold Hospital Trust   (Norway)

^m S MARIA NUOVA HOSPITAL   (Italy)

ⁿ HOSPITAL XERAL CALDE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL DISEASE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PHENOTYPE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR;

ADULT; AGE FACTORS; CROHN DISEASE; EPIDEMIOLOGIC METHODS; HUMANS; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RECURRENCE;

EID: 33746136945     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.084061     Document Type: Article

References (39)

1. Greenstein RJ, Collins MT. Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic? Lancet 2004;364:396-7.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
3. Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
4. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment ana long-term prognosis. Acta Chirurg Scand Suppl, 1979;490:1-84.
5. Walters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004;20:483-96.
6. Stockbrugger R, Russel MG, Shivananda S, et al. EC-IBD: a European effort in inflammatory bowel disease. Eur J Intern Med 2000;11:187-90.
7. Shivananda S, Lennard Jones J, Logon R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-7.
8. Walters FL, Russel MG, Sijbrandij J, et al. Disease outcome of inflammatory bowel disease patients; general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol (in press).
9. Wolters FL, van Zeijl G, Sijbrandij J, et al. Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates. World J Gastroenterol 2005;11:7152-8.
10. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
11. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
12. Cleves MAG, WW, Gutierrez RG. Cox regression models. In: An introduction to survival analysis using Stata. Texas: Stata Press, 2002:119-95.
13. Wolters FL, Russel MG, Sijbrandij J, et al. Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 2006;55:510-18.
14. Post S, Herfarth C, Bohm E, et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg 1996;223:253-60.
15. Steinhart AH, Girgrah N, McLeod RS. Reliability of a Crohn's disease clinical classification scheme based on disease behavior. Inflamm Bowel Dis 1998;4:228-34.
16. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359:1661-5.
17. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123:679-88.
18. Louis E, Michel V, Hugot JP, et al. Early development of structuring or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003;52:552-7.
19. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-prforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
20. Shivananda S, Hordijk ML, Pena AS, et al. Crohn's disease: risk of recurrence and reoperation in a defined population. Gut 1989;30:990-5.
21. Agrez MV, Valente RM, Pierce W, et al. Surgical history of Crohn's disease in a well-defined population. Mayo Clinic Proc 1982;57):747-52.
22. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38-45.
23. Mourn B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997;32:1005-12.
24. Krause U, Ejerblad S, Bergman L. Crohn's disease. A long-term study of the clinical course in 186 patients. Scand J Gastroenterol 1985;20:516-24.
25. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82.
26. 2o Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50.
27. Nemetz A, Molnar T, Zagoni T, et al. Phenotypes defined by the "Vienna classification" in 100 Hungarian patients with Crohn's disease. Rev Esp Enferm Dig. 2003;95:533-8, 527-33).
28. Hamon JF, Carbonnel F, Beaugerie L, et al. Comparison of long-term course of perforating and non-perforating Crohn disease. Gastroenterol Clin Biol 1998;22:601-6.
29. Hofer B, Bottger T, Hernandez-Richter T, et al. The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease. Hepatogastroenterology 2001;48:152-5.
30. Borley NR, Mortensen NJ, Chaudry MA, et al. Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure. Dis Colon Rectum 2002;45:377-83.
31. Borley NR, Mortensen NJ, Chaudry MA, et al. Evidence for separate disease phenotypes in intestinal Crohn's disease. Br J Surg 2002;89:201-5.
32. D'Haens G, Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention. Inflamm Bowel Dis 1999;5:295-303.
33. Aeberhard P, Berchtold W, Riedtmann HJ, et al. Surgical recurrence of perforating and nonperforating Crohn's disease. A study of 101 surgically treated patients. Dis Colon Rectum 1996;39:80-7.
34. Sugita A, Fukushima T, Yamazaki Y, et al. Postoperative recurrence form of Crohn's disease: comparison between perforating and non perforating types. Nippon Geka Gakkai Zasshi 1993;94:114-18.
35. Rutgeerts PJ. Conventional treatment of Crohn's disease: objectives and outcomes. Inflamm Bowel Dis 2001;7(Suppl 1):S2-8.
36. Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 2003;3(2):81-92.
37. Biancone L, Tosti C, Fina D, et al. Review article: maintenance treatment of Crohn's disease. Aliment Pharmacol Ther 2003;17(Suppl 2):31-7.
38. Feagan BG. Maintenance therapy for inflammatory bowel disease. Am J Gastroenterol 2003;98(Suppl):S6-S17.
39. Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997;44:287-302.